ArticleAnnals of hematology2023

Shorter duration of venetoclax administration to 14 days has same efficacy and better safety profile in treatment of acute myeloid leukemia.

Masayuki Aiba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.